RFWE-02 - Rapid fire session from selected oral abstracts
P3-P4
Chair(s)
Dr Joseph M. Guiu-Segura, ExCo member FIPs' Hospital Pharmacy Section’ (Spain)Introduction
During this session selected abstracts from the following topics will be presented in a 7,5-minute presentation:
- Social and admin. pharmacy
- Regulatory sciences and quality
- Hospital pharmacy
Link to selected abstracts to follow
(SEC) Hospital pharmacy- RFWE-02-08 - Safeguarding patient safety via Pakistan’s first Home Grown Bar-coded Medication Administration System Developed and Implemented at a Private Tertiary Care Hospital
- RFWE-02-09 - Documenting for Safety: How Real-Time Documentation of Medication Changes Improve Physician-Pharmacist Communication and Prevent Medication Errors at Discharge
- RFWE-02-11 - Measuring equity of clinical pharmacy service provision at the regional and rural hospitals in Australia
- RFWE-02-12 - Development of pharmaceutical care competency framework in China: a qualitative study in hospital pharmacy
(SEC) Social and administrative pharmacy- RFWE-02-01 - Evaluation of the quality of geriatric pharmacotherapy services for patients with polypharmacy in primary care: A six-month observational study
- RFWE-02-02 - The Role of Pharmacists in Improving Healthcare Outcomes: Analysis Of Interventions On Prescribing Errors In Malaysia
- RFWE-02-03 - Clinical pharmacy service improves medication adherence in patients with chronic kidney disease of uncertain aetiology (CKDu) – a randomized controlled trial from Sri Lanka
- RFWE-02-04 - Navigating the ICER Value Assessment Framework for Rare Disease Treatments
(SIG) Regulatory sciences and quality- RFWE-02-05 - Timely designation of Notified Bodies within the European Union
- RFWE-02-06 - Validation and specificity study on the test of 4-aminophenol in the acetaminophen-containing drug products
- RFWE-02-07 - The African Medicines Agency and Medicines Regulation: Progress, Challenges, and Recommendations
- RFWE-02-08 - Safeguarding patient safety via Pakistan’s first Home Grown Bar-coded Medication Administration System Developed and Implemented at a Private Tertiary Care Hospital
- RFWE-02-09 - Documenting for Safety: How Real-Time Documentation of Medication Changes Improve Physician-Pharmacist Communication and Prevent Medication Errors at Discharge
- RFWE-02-11 - Measuring equity of clinical pharmacy service provision at the regional and rural hospitals in Australia
- RFWE-02-12 - Development of pharmaceutical care competency framework in China: a qualitative study in hospital pharmacy
(SEC) Social and administrative pharmacy- RFWE-02-01 - Evaluation of the quality of geriatric pharmacotherapy services for patients with polypharmacy in primary care: A six-month observational study
- RFWE-02-02 - The Role of Pharmacists in Improving Healthcare Outcomes: Analysis Of Interventions On Prescribing Errors In Malaysia
- RFWE-02-03 - Clinical pharmacy service improves medication adherence in patients with chronic kidney disease of uncertain aetiology (CKDu) – a randomized controlled trial from Sri Lanka
- RFWE-02-04 - Navigating the ICER Value Assessment Framework for Rare Disease Treatments
(SIG) Regulatory sciences and quality- RFWE-02-05 - Timely designation of Notified Bodies within the European Union
- RFWE-02-06 - Validation and specificity study on the test of 4-aminophenol in the acetaminophen-containing drug products
- RFWE-02-07 - The African Medicines Agency and Medicines Regulation: Progress, Challenges, and Recommendations
- RFWE-02-01 - Evaluation of the quality of geriatric pharmacotherapy services for patients with polypharmacy in primary care: A six-month observational study
- RFWE-02-02 - The Role of Pharmacists in Improving Healthcare Outcomes: Analysis Of Interventions On Prescribing Errors In Malaysia
- RFWE-02-03 - Clinical pharmacy service improves medication adherence in patients with chronic kidney disease of uncertain aetiology (CKDu) – a randomized controlled trial from Sri Lanka
- RFWE-02-04 - Navigating the ICER Value Assessment Framework for Rare Disease Treatments
(SIG) Regulatory sciences and quality- RFWE-02-05 - Timely designation of Notified Bodies within the European Union
- RFWE-02-06 - Validation and specificity study on the test of 4-aminophenol in the acetaminophen-containing drug products
- RFWE-02-07 - The African Medicines Agency and Medicines Regulation: Progress, Challenges, and Recommendations
- RFWE-02-05 - Timely designation of Notified Bodies within the European Union
- RFWE-02-06 - Validation and specificity study on the test of 4-aminophenol in the acetaminophen-containing drug products
- RFWE-02-07 - The African Medicines Agency and Medicines Regulation: Progress, Challenges, and Recommendations
